Key takeaway: The $25 Zepbound copay is available to commercially insured patients who qualify for Eli Lilly’s Savings Card program. This is not available to Medicare or Medicaid patients. Uninsured patients may qualify for the LillyDirect self-pay program at approximately $550/month. Telehealth providers like Klarity can help evaluate your eligibility and navigate savings options.
Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →
How to Get Zepbound: Step-by-Step
Check your eligibility: Zepbound is FDA-approved for adults with BMI ≥30, or ≥27 with a weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol.
Choose a telehealth provider: Platforms like Klarity allow you to complete the entire process online. Same-day appointments are often available with 2,000+ licensed providers.
Complete your intake and evaluation: A licensed clinician will review your health history, BMI, and goals (typically 15–30 minutes).
Receive your prescription: If Zepbound is appropriate, your provider sends the prescription to a pharmacy — including mail-order and specialty pharmacies.
Verify your insurance benefits: Many plans may cover Zepbound. Your Klarity provider can help navigate options. Coverage varies by plan. Verify your benefits before booking.
Start treatment and follow up: Zepbound is titrated gradually. Your provider checks in regularly to adjust your dose and manage side effects.
Understanding the $25 Zepbound Savings Program
The Zepbound Savings Card from Eli Lilly is one of the most significant cost-reduction tools available for commercially insured patients. Here’s how it works:
Eligibility: You must have commercial insurance (not Medicare, Medicaid, or other government-funded programs)
Cost reduction: Eligible patients may pay as little as $25/month
Application: Apply through the Lilly Cares Foundation or LillyDirect website
Enrollment: Free to enroll; no income requirements for the commercial insurance tier
Zepbound Pricing Options Summary
Patient Type
Program
Estimated Monthly Cost
Commercially insured (qualifying)
Zepbound Savings Card
As low as $25/month
Self-pay / uninsured
LillyDirect self-pay program
~$550/month (starting dose)
Medicare / Medicaid
Not covered for weight loss (diabetes only)
Full list price (~$1,060–$1,086/mo)
Commercial insurance (coverage)
Standard formulary coverage
Varies by plan deductible and tier
Coverage varies by plan. Verify your benefits before booking.
Other Ways to Save on Zepbound
Prior authorization support: Many insurance plans require prior authorization for Zepbound. Your Klarity provider can assist with this process, documenting medical necessity and BMI qualification.
Mail-order pharmacy: Using a mail-order pharmacy often reduces per-dose cost compared to retail pharmacies.
90-day supplies: Where available, 90-day supplies can reduce per-dose cost versus monthly fills.
Patient assistance programs: Lilly’s Insulins Value Program may offer additional support in some cases. Contact Lilly directly to check eligibility.
Why Insurance Coverage Matters for GLP-1 Medications
The list price of Zepbound exceeds $1,000/month, making insurance coverage critical for most patients. When evaluating insurance coverage for Zepbound:
Confirm whether your plan covers Zepbound specifically (not just “GLP-1 medications” generally)
Ask about the tier placement and associated copay or coinsurance
Check whether prior authorization is required and what documentation is needed
Ask if a step therapy requirement exists (requiring you to try another medication first)
GLP-1 Medications in 2026: What’s New
The GLP-1 landscape has expanded significantly entering 2026, offering patients more options and broader access than ever before.
Tirzepatide expanded indications: Following FDA approvals in 2024–2025, tirzepatide (Zepbound/Mounjaro) has expanded labeling covering additional cardiovascular and metabolic indications, reinforcing its role as a leading dual GIP/GLP-1 receptor agonist for long-term weight management.
Insurance coverage expansion: More commercial insurers added tirzepatide to their formularies in 2025. Medicare Part D coverage for anti-obesity medications remains limited pending TROA legislation. Coverage varies by plan. Verify your benefits before booking.
Oral semaglutide for weight loss: Rybelsus (oral semaglutide) is seeing growing uptake for weight management as patients seek needle-free GLP-1 options.
Triple agonists on the horizon: Retatrutide has shown striking Phase 3 results and may reach the market in 2026–2027.
Compounded tirzepatide status: Availability and legal status of compounded tirzepatide shifted throughout 2024–2025 following FDA rulings. Confirm current regulatory status with your provider before pursuing compounded options.
Telehealth access expanding: Platforms like Klarity offer same-day access to 2,000+ licensed providers for evaluation and ongoing support.
Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →
Frequently Asked Questions
What are GLP-1 medications?
GLP-1 (glucagon-like peptide-1) receptor agonists mimic a natural gut hormone to slow digestion, reduce appetite, and regulate blood sugar. Approved medications include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).
How do I get a GLP-1 prescription?
A licensed provider must evaluate your health history. Telehealth platforms like Klarity allow you to complete this evaluation fully online, often with same-day appointment availability.
Will my insurance cover GLP-1 medications?
Many insurance plans may cover GLP-1 medications when prescribed for qualifying conditions. Coverage varies significantly by plan and insurer. Coverage varies by plan. Verify your benefits before booking.
What should I expect when starting a GLP-1 medication?
Most patients start on a low dose that is gradually increased. Meaningful weight loss typically begins within 4–8 weeks, with peak effects at 12–24 months of consistent use.
How can Klarity help me access GLP-1 treatment?
Klarity connects you with 2,000+ licensed providers across the U.S. Many patients may be able to use insurance to cover their visits. See if you may qualify →
Looking for support with Weight loss? Get expert care from top-rated providers
Find the right provider for your needs — select your state to find expert care near you.